Furthermore, osteopontin (SPP1) upregulation, described in breast cancer as being responsible for merlin degradation (14), may explain the absence of merlin even in schwannomas with no DNA hits in NF2 (5). This evidence concerns the gene NF2 and breast carcinoma.